USA Interventional X-ray Contrast and Imaging Agents Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • A contrast agent (or contrast medium) is a substance used to increase the contrast of structures or fluids within the body in medical imaging.

    This report offers an overview of the market trends, drivers, and barriers with respect to the USA Interventional X-ray Contrast and Imaging Agents market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Interventional X-ray Contrast and Imaging Agents market. Detailed analysis of key players, along with key growth strategies adopted by Interventional X-ray Contrast and Imaging Agents industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Novalek Pharmaceuticals

    • JB Chemicals & Pharmaceuticals

    • Jodas Expoim

    • Imax

    • Bracco

    • Guerbet

    • Taejoon Pharm

    • General Electric

    • Lantheus Medical Imaging

    • Nano Therapeutics

    • Fujifilm Visualsonics

    • Unijules Life Sciences

    By Type:

    • Iodinated Contrast Media

    • Barium-Based Contrast Media

    • Microbubble Contrast Media

    • Other

    By End-User:

    • Heart Disease

    • Neurological

    • Urology

    • General Surgery

    • Other

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Interventional X-ray Contrast and Imaging Agents Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Interventional X-ray Contrast and Imaging Agents Market Size and Growth Rate of Iodinated Contrast Media from 2016 to 2027

      • 1.3.2 USA Interventional X-ray Contrast and Imaging Agents Market Size and Growth Rate of Barium-Based Contrast Media from 2016 to 2027

      • 1.3.3 USA Interventional X-ray Contrast and Imaging Agents Market Size and Growth Rate of Microbubble Contrast Media from 2016 to 2027

      • 1.3.4 USA Interventional X-ray Contrast and Imaging Agents Market Size and Growth Rate of Other from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Interventional X-ray Contrast and Imaging Agents Market Size and Growth Rate of Heart Disease from 2016 to 2027

      • 1.4.2 USA Interventional X-ray Contrast and Imaging Agents Market Size and Growth Rate of Neurological from 2016 to 2027

      • 1.4.3 USA Interventional X-ray Contrast and Imaging Agents Market Size and Growth Rate of Urology from 2016 to 2027

      • 1.4.4 USA Interventional X-ray Contrast and Imaging Agents Market Size and Growth Rate of General Surgery from 2016 to 2027

      • 1.4.5 USA Interventional X-ray Contrast and Imaging Agents Market Size and Growth Rate of Other from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Interventional X-ray Contrast and Imaging Agents Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Interventional X-ray Contrast and Imaging Agents Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Interventional X-ray Contrast and Imaging Agents Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Interventional X-ray Contrast and Imaging Agents Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Interventional X-ray Contrast and Imaging Agents Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Interventional X-ray Contrast and Imaging Agents by Major Types

      • 3.4.1 Market Size and Growth Rate of Iodinated Contrast Media

      • 3.4.2 Market Size and Growth Rate of Barium-Based Contrast Media

      • 3.4.3 Market Size and Growth Rate of Microbubble Contrast Media

      • 3.4.4 Market Size and Growth Rate of Other

    4 Segmentation of Interventional X-ray Contrast and Imaging Agents Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Interventional X-ray Contrast and Imaging Agents by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Interventional X-ray Contrast and Imaging Agents in Heart Disease

      • 4.4.2 Market Size and Growth Rate of Interventional X-ray Contrast and Imaging Agents in Neurological

      • 4.4.3 Market Size and Growth Rate of Interventional X-ray Contrast and Imaging Agents in Urology

      • 4.4.4 Market Size and Growth Rate of Interventional X-ray Contrast and Imaging Agents in General Surgery

      • 4.4.5 Market Size and Growth Rate of Interventional X-ray Contrast and Imaging Agents in Other

    5 Market Analysis by Regions

    • 5.1 USA Interventional X-ray Contrast and Imaging Agents Production Analysis by Regions

    • 5.2 USA Interventional X-ray Contrast and Imaging Agents Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Interventional X-ray Contrast and Imaging Agents Landscape Analysis

    • 6.1 West USA Interventional X-ray Contrast and Imaging Agents Landscape Analysis by Major Types

    • 6.2 West USA Interventional X-ray Contrast and Imaging Agents Landscape Analysis by Major End-Users

    7 South USA Interventional X-ray Contrast and Imaging Agents Landscape Analysis

    • 7.1 South USA Interventional X-ray Contrast and Imaging Agents Landscape Analysis by Major Types

    • 7.2 South USA Interventional X-ray Contrast and Imaging Agents Landscape Analysis by Major End-Users

    8 Middle West USA Interventional X-ray Contrast and Imaging Agents Landscape Analysis

    • 8.1 Middle West USA Interventional X-ray Contrast and Imaging Agents Landscape Analysis by Major Types

    • 8.2 Middle West USA Interventional X-ray Contrast and Imaging Agents Landscape Analysis by Major End-Users

    9 Northeast USA Interventional X-ray Contrast and Imaging Agents Landscape Analysis

    • 9.1 Northeast USA Interventional X-ray Contrast and Imaging Agents Landscape Analysis by Major Types

    • 9.2 Northeast USA Interventional X-ray Contrast and Imaging Agents Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Novalek Pharmaceuticals

        • 10.1.1 Novalek Pharmaceuticals Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 JB Chemicals & Pharmaceuticals

        • 10.2.1 JB Chemicals & Pharmaceuticals Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 Jodas Expoim

        • 10.3.1 Jodas Expoim Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Imax

        • 10.4.1 Imax Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 Bracco

        • 10.5.1 Bracco Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 Guerbet

        • 10.6.1 Guerbet Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 Taejoon Pharm

        • 10.7.1 Taejoon Pharm Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 General Electric

        • 10.8.1 General Electric Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 Lantheus Medical Imaging

        • 10.9.1 Lantheus Medical Imaging Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

      • 10.10 Nano Therapeutics

        • 10.10.1 Nano Therapeutics Company Profile and Recent Development

        • 10.10.2 Market Performance

        • 10.10.3 Product and Service Introduction

      • 10.11 Fujifilm Visualsonics

        • 10.11.1 Fujifilm Visualsonics Company Profile and Recent Development

        • 10.11.2 Market Performance

        • 10.11.3 Product and Service Introduction

      • 10.12 Unijules Life Sciences

        • 10.12.1 Unijules Life Sciences Company Profile and Recent Development

        • 10.12.2 Market Performance

        • 10.12.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Interventional X-ray Contrast and Imaging Agents Market Size and Growth Rate of Iodinated Contrast Media from 2016 to 2027

    • Figure USA Interventional X-ray Contrast and Imaging Agents Market Size and Growth Rate of Barium-Based Contrast Media from 2016 to 2027

    • Figure USA Interventional X-ray Contrast and Imaging Agents Market Size and Growth Rate of Microbubble Contrast Media from 2016 to 2027

    • Figure USA Interventional X-ray Contrast and Imaging Agents Market Size and Growth Rate of Other from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Interventional X-ray Contrast and Imaging Agents Market Size and Growth Rate of Heart Disease from 2016 to 2027

    • Figure USA Interventional X-ray Contrast and Imaging Agents Market Size and Growth Rate of Neurological from 2016 to 2027

    • Figure USA Interventional X-ray Contrast and Imaging Agents Market Size and Growth Rate of Urology from 2016 to 2027

    • Figure USA Interventional X-ray Contrast and Imaging Agents Market Size and Growth Rate of General Surgery from 2016 to 2027

    • Figure USA Interventional X-ray Contrast and Imaging Agents Market Size and Growth Rate of Other from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Interventional X-ray Contrast and Imaging Agents Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Interventional X-ray Contrast and Imaging Agents Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Interventional X-ray Contrast and Imaging Agents Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Interventional X-ray Contrast and Imaging Agents Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Interventional X-ray Contrast and Imaging Agents Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Interventional X-ray Contrast and Imaging Agents

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Interventional X-ray Contrast and Imaging Agents by Different Types from 2016 to 2027

    • Table Consumption Share of Interventional X-ray Contrast and Imaging Agents by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Iodinated Contrast Media

    • Figure Market Size and Growth Rate of Barium-Based Contrast Media

    • Figure Market Size and Growth Rate of Microbubble Contrast Media

    • Figure Market Size and Growth Rate of Other

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Interventional X-ray Contrast and Imaging Agents by Different End-Users from 2016 to 2027

    • Table Consumption Share of Interventional X-ray Contrast and Imaging Agents by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Heart Disease

    • Figure Market Size and Growth Rate of Neurological

    • Figure Market Size and Growth Rate of Urology

    • Figure Market Size and Growth Rate of General Surgery

    • Figure Market Size and Growth Rate of Other

    • Table USA Interventional X-ray Contrast and Imaging Agents Production by Regions

    • Table USA Interventional X-ray Contrast and Imaging Agents Production Share by Regions

    • Figure USA Interventional X-ray Contrast and Imaging Agents Production Share by Regions in 2016

    • Figure USA Interventional X-ray Contrast and Imaging Agents Production Share by Regions in 2021

    • Figure USA Interventional X-ray Contrast and Imaging Agents Production Share by Regions in 2027

    • Table USA Interventional X-ray Contrast and Imaging Agents Consumption by Regions

    • Table USA Interventional X-ray Contrast and Imaging Agents Consumption Share by Regions

    • Figure USA Interventional X-ray Contrast and Imaging Agents Consumption Share by Regions in 2016

    • Figure USA Interventional X-ray Contrast and Imaging Agents Consumption Share by Regions in 2021

    • Figure USA Interventional X-ray Contrast and Imaging Agents Consumption Share by Regions in 2027

    • Table West USA Interventional X-ray Contrast and Imaging Agents Consumption by Types from 2016 to 2027

    • Table West USA Interventional X-ray Contrast and Imaging Agents Consumption Share by Types from 2016 to 2027

    • Figure West USA Interventional X-ray Contrast and Imaging Agents Consumption Share by Types in 2016

    • Figure West USA Interventional X-ray Contrast and Imaging Agents Consumption Share by Types in 2021

    • Figure West USA Interventional X-ray Contrast and Imaging Agents Consumption Share by Types in 2027

    • Table West USA Interventional X-ray Contrast and Imaging Agents Consumption by End-Users from 2016 to 2027

    • Table West USA Interventional X-ray Contrast and Imaging Agents Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Interventional X-ray Contrast and Imaging Agents Consumption Share by End-Users in 2016

    • Figure West USA Interventional X-ray Contrast and Imaging Agents Consumption Share by End-Users in 2021

    • Figure West USA Interventional X-ray Contrast and Imaging Agents Consumption Share by End-Users in 2027

    • Table South USA Interventional X-ray Contrast and Imaging Agents Consumption by Types from 2016 to 2027

    • Table South USA Interventional X-ray Contrast and Imaging Agents Consumption Share by Types from 2016 to 2027

    • Figure South USA Interventional X-ray Contrast and Imaging Agents Consumption Share by Types in 2016

    • Figure South USA Interventional X-ray Contrast and Imaging Agents Consumption Share by Types in 2021

    • Figure South USA Interventional X-ray Contrast and Imaging Agents Consumption Share by Types in 2027

    • Table South USA Interventional X-ray Contrast and Imaging Agents Consumption by End-Users from 2016 to 2027

    • Table South USA Interventional X-ray Contrast and Imaging Agents Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Interventional X-ray Contrast and Imaging Agents Consumption Share by End-Users in 2016

    • Figure South USA Interventional X-ray Contrast and Imaging Agents Consumption Share by End-Users in 2021

    • Figure South USA Interventional X-ray Contrast and Imaging Agents Consumption Share by End-Users in 2027

    • Table Middle West USA Interventional X-ray Contrast and Imaging Agents Consumption by Types from 2016 to 2027

    • Table Middle West USA Interventional X-ray Contrast and Imaging Agents Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Interventional X-ray Contrast and Imaging Agents Consumption Share by Types in 2016

    • Figure Middle West USA Interventional X-ray Contrast and Imaging Agents Consumption Share by Types in 2021

    • Figure Middle West USA Interventional X-ray Contrast and Imaging Agents Consumption Share by Types in 2027

    • Table Middle West USA Interventional X-ray Contrast and Imaging Agents Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Interventional X-ray Contrast and Imaging Agents Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Interventional X-ray Contrast and Imaging Agents Consumption Share by End-Users in 2016

    • Figure Middle West USA Interventional X-ray Contrast and Imaging Agents Consumption Share by End-Users in 2021

    • Figure Middle West USA Interventional X-ray Contrast and Imaging Agents Consumption Share by End-Users in 2027

    • Table Northeast USA Interventional X-ray Contrast and Imaging Agents Consumption by Types from 2016 to 2027

    • Table Northeast USA Interventional X-ray Contrast and Imaging Agents Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Interventional X-ray Contrast and Imaging Agents Consumption Share by Types in 2016

    • Figure Northeast USA Interventional X-ray Contrast and Imaging Agents Consumption Share by Types in 2021

    • Figure Northeast USA Interventional X-ray Contrast and Imaging Agents Consumption Share by Types in 2027

    • Table Northeast USA Interventional X-ray Contrast and Imaging Agents Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Interventional X-ray Contrast and Imaging Agents Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Interventional X-ray Contrast and Imaging Agents Consumption Share by End-Users in 2016

    • Figure Northeast USA Interventional X-ray Contrast and Imaging Agents Consumption Share by End-Users in 2021

    • Figure Northeast USA Interventional X-ray Contrast and Imaging Agents Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Novalek Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novalek Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Novalek Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Novalek Pharmaceuticals

    • Table Product and Service Introduction of Novalek Pharmaceuticals

    • Table Company Profile and Development Status of JB Chemicals & Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of JB Chemicals & Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of JB Chemicals & Pharmaceuticals

    • Figure Revenue and Market Share Analysis of JB Chemicals & Pharmaceuticals

    • Table Product and Service Introduction of JB Chemicals & Pharmaceuticals

    • Table Company Profile and Development Status of Jodas Expoim

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Jodas Expoim

    • Figure Sales and Growth Rate Analysis of Jodas Expoim

    • Figure Revenue and Market Share Analysis of Jodas Expoim

    • Table Product and Service Introduction of Jodas Expoim

    • Table Company Profile and Development Status of Imax

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Imax

    • Figure Sales and Growth Rate Analysis of Imax

    • Figure Revenue and Market Share Analysis of Imax

    • Table Product and Service Introduction of Imax

    • Table Company Profile and Development Status of Bracco

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bracco

    • Figure Sales and Growth Rate Analysis of Bracco

    • Figure Revenue and Market Share Analysis of Bracco

    • Table Product and Service Introduction of Bracco

    • Table Company Profile and Development Status of Guerbet

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Guerbet

    • Figure Sales and Growth Rate Analysis of Guerbet

    • Figure Revenue and Market Share Analysis of Guerbet

    • Table Product and Service Introduction of Guerbet

    • Table Company Profile and Development Status of Taejoon Pharm

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Taejoon Pharm

    • Figure Sales and Growth Rate Analysis of Taejoon Pharm

    • Figure Revenue and Market Share Analysis of Taejoon Pharm

    • Table Product and Service Introduction of Taejoon Pharm

    • Table Company Profile and Development Status of General Electric

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of General Electric

    • Figure Sales and Growth Rate Analysis of General Electric

    • Figure Revenue and Market Share Analysis of General Electric

    • Table Product and Service Introduction of General Electric

    • Table Company Profile and Development Status of Lantheus Medical Imaging

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lantheus Medical Imaging

    • Figure Sales and Growth Rate Analysis of Lantheus Medical Imaging

    • Figure Revenue and Market Share Analysis of Lantheus Medical Imaging

    • Table Product and Service Introduction of Lantheus Medical Imaging

    • Table Company Profile and Development Status of Nano Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nano Therapeutics

    • Figure Sales and Growth Rate Analysis of Nano Therapeutics

    • Figure Revenue and Market Share Analysis of Nano Therapeutics

    • Table Product and Service Introduction of Nano Therapeutics

    • Table Company Profile and Development Status of Fujifilm Visualsonics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Fujifilm Visualsonics

    • Figure Sales and Growth Rate Analysis of Fujifilm Visualsonics

    • Figure Revenue and Market Share Analysis of Fujifilm Visualsonics

    • Table Product and Service Introduction of Fujifilm Visualsonics

    • Table Company Profile and Development Status of Unijules Life Sciences

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Unijules Life Sciences

    • Figure Sales and Growth Rate Analysis of Unijules Life Sciences

    • Figure Revenue and Market Share Analysis of Unijules Life Sciences

    • Table Product and Service Introduction of Unijules Life Sciences


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.